Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wickenden

Showing results (161-170 of 194) with videos related to

Pageof 20
Sort By:
Oncotarget|February 10, 2018
Identification of survivin as a promising target for the immunotherapy of adult B-cell acute lymphoblastic leukemiaLaurie Freire Boullosa, Payalben Savaliya, Stephanie Bonney, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 11, 2007
Pharmacology and antitussive efficacy of 4-(3-trifluoromethyl-pyridin-2-yl)-piperazine-1-carboxylic acid (5-trifluoromethyl-pyridin-2-yl)-amide (JNJ17203212), a transient receptor potential vanilloid 1 antagonist in guinea pigsAnindya Bhattacharya, Brian P Scott, Nadia Nasser, et al.
Microbial Genomics|June 8, 2022
Local accessory gene sharing among Egyptian <i>Campylobacter</i> potentially promotes the spread of antimicrobial resistanceShaimaa F Mouftah, Ben Pascoe, Jessica K Calland, et al.
Plos One|May 10, 2023
The development, implementation, and evaluation of an optimal model for the case detection, referral, and case management of Neglected Tropical DiseasesTiawanlyn G Godwin-Akpan, Shahreen Chowdhury, Emerson J Rogers, et al.
PLOS Global Public Health|December 10, 2025
'We cannot just keep it in our palm': A policy analysis of the integration of the case management of neglected tropical diseases into the health system of LiberiaAnna Wickenden, Laura Dean, Sassy Molyneux, et al.
The Lancet. Oncology|September 7, 2016
30-day mortality after systemic anticancer treatment for breast and lung cancer in England: a population-based, observational studyMichael Wallington, Emma B Saxon, Martine Bomb, et al.
The Journal of Biological Chemistry|December 25, 2019
Comprehensive engineering of the tarantula venom peptide huwentoxin-IV to inhibit the human voltage-gated sodium channel hNa<sub>v</sub>1.7Robert A Neff, Mack Flinspach, Alan Gibbs, et al.
Parasitology|November 6, 2023
Unpacking the impact of integrating the neglected tropical disease supply chain into the national supply chain system: illustrative evidence from LiberiaKarsor K Kollie, Jack Jenkins, Sally Theobald, et al.
Bioorganic & Medicinal Chemistry Letters|August 10, 2011
Discovery of a novel series of selective HCN1 blockersKelly J McClure, Michael Maher, Nancy Wu, et al.
European Journal of Pharmacology|April 10, 2019
Pharmacology of JNJ-28583113: A novel TRPM2 antagonistLawrence Fourgeaud, Curt Dvorak, Malika Faouzi, et al.
Pageof 20

Showing results (161-170 of 194) with videos related to

Sort By:
Pageof 20
Oncotarget|February 10, 2018
Identification of survivin as a promising target for the immunotherapy of adult B-cell acute lymphoblastic leukemiaLaurie Freire Boullosa, Payalben Savaliya, Stephanie Bonney, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 11, 2007
Pharmacology and antitussive efficacy of 4-(3-trifluoromethyl-pyridin-2-yl)-piperazine-1-carboxylic acid (5-trifluoromethyl-pyridin-2-yl)-amide (JNJ17203212), a transient receptor potential vanilloid 1 antagonist in guinea pigsAnindya Bhattacharya, Brian P Scott, Nadia Nasser, et al.
Microbial Genomics|June 8, 2022
Local accessory gene sharing among Egyptian <i>Campylobacter</i> potentially promotes the spread of antimicrobial resistanceShaimaa F Mouftah, Ben Pascoe, Jessica K Calland, et al.
Plos One|May 10, 2023
The development, implementation, and evaluation of an optimal model for the case detection, referral, and case management of Neglected Tropical DiseasesTiawanlyn G Godwin-Akpan, Shahreen Chowdhury, Emerson J Rogers, et al.
PLOS Global Public Health|December 10, 2025
'We cannot just keep it in our palm': A policy analysis of the integration of the case management of neglected tropical diseases into the health system of LiberiaAnna Wickenden, Laura Dean, Sassy Molyneux, et al.
The Lancet. Oncology|September 7, 2016
30-day mortality after systemic anticancer treatment for breast and lung cancer in England: a population-based, observational studyMichael Wallington, Emma B Saxon, Martine Bomb, et al.
The Journal of Biological Chemistry|December 25, 2019
Comprehensive engineering of the tarantula venom peptide huwentoxin-IV to inhibit the human voltage-gated sodium channel hNa<sub>v</sub>1.7Robert A Neff, Mack Flinspach, Alan Gibbs, et al.
Parasitology|November 6, 2023
Unpacking the impact of integrating the neglected tropical disease supply chain into the national supply chain system: illustrative evidence from LiberiaKarsor K Kollie, Jack Jenkins, Sally Theobald, et al.
Bioorganic & Medicinal Chemistry Letters|August 10, 2011
Discovery of a novel series of selective HCN1 blockersKelly J McClure, Michael Maher, Nancy Wu, et al.
European Journal of Pharmacology|April 10, 2019
Pharmacology of JNJ-28583113: A novel TRPM2 antagonistLawrence Fourgeaud, Curt Dvorak, Malika Faouzi, et al.
Pageof 20